Biodegradable Nanoparticles Improve Oral Bioavailability of Amphotericin B and Show Reduced Nephrotoxicity Compared to Intravenous Fungizone®

By Italia J.   Yahya M.   Singh D.   Ravi Kumar M.  

Pharmaceutical Research, Vol. 26, Iss. 6, 2009-06 ,pp. : 1324-1331

Springer Publishing Company

Access to resources Recommend Favorite

Heat-Treated Fungizone Retains Amphotericin B Antifungal Activity Without Renal Toxicity in Rats Infected with Aspergillus Fumigatus

By Sivak Olena   Bartlett Karen   Wasan Kishor M.  

Pharmaceutical Research, Vol. 21, Iss. 9, 2004-09 ,pp. : 1564-1566

Springer Publishing Company

Access to resources Recommend Favorite

Differences in human phospholipid transfer protein activity following incubation of Fungizone® compared to lipid-based Amphotericin-B formulations in normolipidemic and hyperlipidemic plasma

By Henderson Ryan J.   Leon Carlos G.   Wasan Kishor M.  

Drug Development and Industrial Pharmacy, Vol. 35, Iss. 9, 2009-09 ,pp. : 1139-1146

Informa Healthcare

Access to resources Recommend Favorite

Amphotericin B overdose: Death due to medication error: case report

By  

Reactions Weekly, Vol. 1, Iss. 1047, 2005-01 ,pp. : 6-6

Adis International

Access to resources Recommend Favorite

Amphotericin B overdose: Nephrotoxicity following inadvertent administration: case report

By  

Reactions Weekly, Vol. 1, Iss. 1426, 2012-01 ,pp. : 9-9

Adis International

Access to resources Recommend Favorite